Year Established :
2200
Main Competitive Advantages :
Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO)
Business Type :
All
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
Western Europe,Eastern Europe,Asia,Middle East
Product Range :
"盐酸度洛西汀 Duloxetine HCl"
"左乙拉西坦 Levetiracetam"
"奥美拉唑 Omeprazole"
"盐酸环丙沙星 Ciprofloxacin hydrochloride"
"米拉贝隆 Mirabegron"
琥珀酸索利那新 Solifinacine
"帕博西尼 Palbociclib"
"甲磺酸乐伐替尼 Lenvatinib"
"坎格列净半水合物 Canagliflozin Hemihydrate"
"恩格列净 Empagliflozin"
"琥珀酸曲格列汀 Trelagliptin Succinate"
"马西腾坦 Macitentan
""西里帕格 Selexipag"
"阿普斯特 Apremilast"
非布司他 Febsuxtat
"枸橼酸托法替布 Tofacitinib Citrate"
"氟班色林 Flibanserin"
" 富马酸沃诺拉赞 Vonoprazan Fumarate"